|
Form 8-K Cellectar Biosciences, For: May 14
StreetInsider.com Based on its review to date, the Company anticipates that the restatements will relate to the accounting for common stock purchase warrants issued by the Company in August 2014 (the “August 2014 Warrants”). The August 2014 Warrants contain a cash … |
